:format(webp))
Microdosing
Lower-dose protocols and how they differ from standard dosing.
:format(webp))
MicrodosingCan I take a half dose of Ozempic?
Ozempic (active ingredient: semaglutide) is an FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist made by Novo Nordisk. It is used to lower blood sugar in people with type 2 diabetes and is also used off-label for weight loss in people with obesity and overweight.
Read the guide:format(webp))
MicrodosingMicrodosing GLP-1s: A complete guide to risks, benefits, and protocols
Glucagon-like peptide-1 receptor agonists (semaglutide and tirzepatide) are a class of medications approved by the U.S. Food and Drug Administration (FDA)
:format(webp))
MicrodosingMicrodosing tirzepatide chart: A complete guide to benefits, dosage and safety
Tirzepatide, a dual GIP/GLP-1 agonist, is available under two brand names: Mounjaro and Zepbound. The medication occupies both receptors simultaneously to suppress appetite and regulate blood glucose levels.
:format(webp))
MicrodosingMicrodosing semaglutide chart: The complete guide to safe, effective low-dose use
Semaglutide, a GLP-1 receptor agonist, has three brand names: Ozempic, Wegovy, and Rybelsus, each approved by the FDA for different indications. Ozempic and Rybelsus are approved for type 2 diabetes, and Wegovy is primarily indicated for weight management in obese and overweight patients, when used along with healthy lifestyle modifications and caloric restrictions.
:format(webp))
MicrodosingMicrodosing Ozempic: The complete guide to safe, effective low-dose use
Ozempic is an FDA-approved GLP-1 (glucagon-like peptide-1) receptor agonist, which is injected subcutaneously once weekly. Semaglutide mimics the activity of a natural hormone (GLP-1), which is released from your intestine and brain in response to food and regulates your body’s sugar level and metabolism.